tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XNCR Stock Latest News

Xencor’s Promising Oncology and Autoimmune Advances Justify Buy Rating with $38 Price Target
RatingsXencor’s Promising Oncology and Autoimmune Advances Justify Buy Rating with $38 Price Target
17h ago
XNCR
Xencor price target raised to $42 from $40 at Cantor Fitzgerald
PremiumThe Fly
Xencor price target raised to $42 from $40 at Cantor Fitzgerald
2d ago
XNCR
Xencor price target lowered to $18 from $20 at JPMorgan
PremiumThe Fly
Xencor price target lowered to $18 from $20 at JPMorgan
2d ago
XNCR
Xencor Reports Improved Q3 2025 Financial Results
PremiumCompany Announcements
Xencor Reports Improved Q3 2025 Financial Results
2d ago
XNCR
Xencor’s Promising Clinical Updates and Strong Efficacy Support Buy Rating
PremiumRatings
Xencor’s Promising Clinical Updates and Strong Efficacy Support Buy Rating
2d ago
XNCR
Promising Developments in Xencor’s Oncology and Autoimmune Pipelines Justify Buy Rating
PremiumRatingsPromising Developments in Xencor’s Oncology and Autoimmune Pipelines Justify Buy Rating
2d ago
XNCR
Xencor reports Q3 EPS (8c), consensus (70c)
Premium
The Fly
Xencor reports Q3 EPS (8c), consensus (70c)
2d ago
XNCR
Beaten Down by 35%-Plus: Analysts Say These 2 Oversold Stocks Are Poised to Turn the Corner
Premium
Stock Analysis & Ideas
Beaten Down by 35%-Plus: Analysts Say These 2 Oversold Stocks Are Poised to Turn the Corner
4d ago
GKOS
XNCR
Xencor upgraded to Overweight from Underweight at Barclays
PremiumThe Fly
Xencor upgraded to Overweight from Underweight at Barclays
10d ago
XNCR
Xencor Inc.’s XmAb541: A Promising Phase 1 Study in Advanced Solid Tumors
PremiumCompany Announcements
Xencor Inc.’s XmAb541: A Promising Phase 1 Study in Advanced Solid Tumors
11d ago
XNCR
Xencor’s XmAb819 Study: A Promising Step in Cancer Treatment
PremiumCompany Announcements
Xencor’s XmAb819 Study: A Promising Step in Cancer Treatment
11d ago
XNCR
Xencor’s Promising NSCLC Study: A Potential Game-Changer?
PremiumCompany Announcements
Xencor’s Promising NSCLC Study: A Potential Game-Changer?
12d ago
XNCR
Xencor’s XmAb942 Study: A New Hope for Ulcerative Colitis?
PremiumCompany AnnouncementsXencor’s XmAb942 Study: A New Hope for Ulcerative Colitis?
12d ago
XNCR
Xencor price target raised to $15 from $14 at BofA
Premium
The Fly
Xencor price target raised to $15 from $14 at BofA
12d ago
XNCR
Positive Outlook for Xencor Amid Promising Trial Data and Strategic Growth Plans
Premium
Ratings
Positive Outlook for Xencor Amid Promising Trial Data and Strategic Growth Plans
12d ago
XNCR
Xencor presents initial data for XmAb819
PremiumThe Fly
Xencor presents initial data for XmAb819
12d ago
XNCR
Xencor price target raised to $18 from $15 at RBC Capital
PremiumThe Fly
Xencor price target raised to $18 from $15 at RBC Capital
12d ago
XNCR
Xencor’s Promising T-Cell Engager Developments Drive Buy Rating
PremiumRatings
Xencor’s Promising T-Cell Engager Developments Drive Buy Rating
14d ago
XNCR
Xencor Reports Initial Results from Phase 1 Studies
PremiumCompany Announcements
Xencor Reports Initial Results from Phase 1 Studies
15d ago
8K
XNCR
Xencor price target raised to $14 from $12 at BofA
PremiumThe FlyXencor price target raised to $14 from $12 at BofA
25d ago
XNCR
Xencor assumed with an Underweight at Barclays
Premium
The Fly
Xencor assumed with an Underweight at Barclays
2M ago
XNCR
Xencor initiated with an Underweight at Barclays
Premium
The Fly
Xencor initiated with an Underweight at Barclays
2M ago
XNCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >